Back to top
more

Grayscale Bitcoin Adopters ETF: (BCOR)

(Delayed Data from NYSE) As of Aug 5, 2025 03:55 PM ET

$31.90 USD

31.9042
692

-0.67 (-2.09%)

Volume: 692

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

Zacks News

Zacks Equity Research

Here's Why Investors Should Hold on to MAXIMUS (MMS) Stock

Long-term contracts provide MAXIMUS (MMS) predictable recurring revenue streams.

Nitish Marwah headshot

4 Stocks With High Net Income Ratio to Scoop Up

Profitability analysis is one of the best ways to evaluate the prospects of a company.

Zacks Equity Research

Here's Why You Should Hold on to Rollins (ROL) Stock Now

Rollins' (ROL) top line benefits from a balanced approach to organic and inorganic growth. However, rising expenses put pressure on the bottom line

Sumit Singh headshot

5 Low P/CF Stocks for a Solid Portfolio Amid Coronavirus Crisis

Investment in stocks made on diligent value analysis is usually considered one of the best practices. In value investing, investors pick stocks that are cheap but fundamentally sound.

Zacks Equity Research

Intuit's Latest Product to Help Americans Get Stimulus Check

Intuit (INTU) partners with Internal Revenue Service (IRS) to announce a free Stimulus Registration product via TurboTax, through which citizens with no tax liabilities can apply for stimulus money.

Zacks Equity Research

Accenture Snaps Up Yesler to Boost B2B Marketing Services

The buyout enables Accenture (ACN) to bolster its account-based marketing, sales enablement, customer advocacy and marketing automation offerings.

Zacks Equity Research

Booz Allen Unveils Resilience Program to Combat Coronavirus

The program aims at enhancing employment security and benefits that Booz Allen (BAH) offers.

Kinjel Shah headshot

6 Low Price-to-Book Stocks to Buy in April

Though price-to-earnings and price-to-sales are the first choices, the P/B ratio is also a convenient tool for identifying valuable stocks.

Zacks Equity Research

FactSet (FDS) Beats Q2 Earnings Estimates, Lags Revenues

FactSet's (FDS) second-quarter fiscal 2020 results benefit from higher sales of analytics, wealth management, content and technology solutions, and lower tax rate.

Zacks Equity Research

US Ecology Strengthens Cash Position Amid Coronavirus Crisis

US Ecology (ECOL) announces steps to counter the adverse financial impacts of the coronavirus pandemic.

Zacks Equity Research

Envestnet Picks CEO, President, Board Chairman & Vice Chairman

These appointments seem to be part of Envestnet's (ENV) efforts to enhance employee skills and improve offerings.

    Zacks Equity Research

    Paychex Unveils Support Plans for SMBs Amid Coronavirus Crisis

    Paychex's (PAYX) compliance support is aimed at enabling businesses manage provision of the Families First Coronavirus Response Act and CARES Act.

      Zacks Equity Research

      J.B. Hunt (JBHT) Rides on DCS Segment Amid High Debt Levels

      Strong revenues at the DCS segment are aiding growth of J.B.Hunt (JBHT). However, sluggish freight demand and high debt levels are concerning.

      Zacks Equity Research

      Rollins (ROL) Raises Paid Time Off Amid Coronavirus Outbreak

      Rollins (ROL) is currently offering 80 hours of PTO to full-time employees and 40 hours to part-time employees for emergency leave.

      Zacks Equity Research

      Insperity Forms Support Team for SMBs Amid Coronavirus Crisis

      Insperity (NSP) remains fully operational amid the coronavirus pandemic, leveraging on its well-established business continuity plan that succeeded during Hurricane Harvey in 2017.

      Zacks Equity Research

      BCOR or TRI: Which Is the Better Value Stock Right Now?

      BCOR vs. TRI: Which Stock Is the Better Value Option?

      Zacks Equity Research

      Here's Why You Should Hold on to Waste Management (WM) Now

      Waste Management's (WM) core operating and cost-cut initiatives, along with shareholder-friendly measures are aiding growth. However, its high debt levels are worrisome.

      Zacks Equity Research

      Rollins' Orkin Starts Disinfection Service Amid Coronavirus Scare

      Rollins' (ROL) move makes sense as public health concerns are increasing across the world amid the coronavirus pandemic.

      Zacks Equity Research

      Here's Why You Should Invest in Omnicom (OMC) Stock Now

      Consistency and diversity of operations, as well as consumer-centric business solutions ensure Omnicom's (OMC) uninterrupted profitability. Its shareholder-friendly measures are also impressive

      Zacks Equity Research

      Here's Why You Should Invest in Charles River (CRAI) Now

      Charles River (CRAI) has a strong international presence that enables it to work with world's leading professionals on multiple aspects.

      Zacks Equity Research

      BCOR or TRI: Which Is the Better Value Stock Right Now?

      BCOR vs. TRI: Which Stock Is the Better Value Option?

      Zacks Equity Research

      Analysts Estimate Blucora (BCOR) to Report a Decline in Earnings: What to Look Out for

      Blucora (BCOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

      Zacks Equity Research

      Blucora (BCOR) Reports Q3 Loss, Tops Revenue Estimates

      Blucora (BCOR) delivered earnings and revenue surprises of 4.76% and 0.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

      Zacks Equity Research

      Analysts Estimate Blucora (BCOR) to Report a Decline in Earnings: What to Look Out for

      Blucora (BCOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

      Zacks Equity Research

      Earnings Preview: Blucora (BCOR) Q3 Earnings Expected to Decline

      Blucora (BCOR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.